Sucampo Receives Notice That Second Indication for AMITIZA for Opioid-Induced Constipation Is Not Approved by …
Sucampo Receives Notice that Second Indication for AMITIZA for Opioid-Induced Constipation Is Not Approved by …
BETHESDA, Md. — Sucampo Pharmaceuticals, Inc. (Sucampo) today announced that Sucampo Pharma Europe, Ltd., its wholly owned subsidiary, has received a notice of refusal to grant a Type II variation for …
Methadone Treatment – Yahoo News Search Results